Tag: Pharmaceutical Innovation
Future of Weight Loss Drugs: Insights from Eli Lilly’s Top Scientist
Dan Skovronsky, the chief scientific officer at Eli Lilly, is at the forefront of developing groundbreaking obesity drugs. With the success of Zepbound, a weekly shot from the pharmaceutical giant, Skovronsky is now focused...
FDA Approves Johnson & Johnson Nasal Spray for Depression: Standalone Treatment Option
BREAKING NEWS: FDA Approves Johnson & Johnson Nasal Spray for DepressionThe Food and Drug Administration has officially given the green light to Johnson & Johnson's nasal spray, Spravato, for standalone use in...
